Neuroinflammation plays a central role in the pathogenesis of various brain disorders, including neurodegenerative diseases, traumatic brain injury, and psychiatric conditions. In the context of neuroinflammation and brain disorders, this inflammatory response within the central nervous system is often triggered by injury, infection, or chronic disease, leading to the activation of microglia and astrocytes, which contribute to neuronal damage. Research has demonstrated that neuroinflammation accelerates disease progression in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, further driving cognitive decline. Understanding the molecular mechanisms behind neuroinflammation is crucial for developing effective therapeutic strategies. Targeting inflammatory pathways with specific drugs, such as cytokine inhibitors or immune-modulatory agents, holds promise in treating these disorders, aiming to reduce neuronal damage and preserve brain function.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States